Peptone
Designs therapeutic proteins using biophysics and advanced computational modeling.
What they do
Peptone focuses on developing therapeutics for intrinsically disordered proteins. By combining advanced biophysical techniques with generative machine learning, they help pharmaceutical researchers design stable proteins to target diseases that lack traditional structured drug targets.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- Protein therapeutics
- Product type
- Platform software
- Stage
- Series A
- Headquarters
- London, United Kingdom
- Region
- Europe
- Founded
- 2016
- Total funding
- $40M raised
Notable investors: F-Prime Capital, Bessemer Venture Partners, Hoxton Ventures, dRx Capital.